Pharmacotherapy is the cornerstone of osteoporosis treatment in general population settings, using medications such as bisphosphonates and anabolic agents such as estrogen receptor modulators and bone formation stimulators such as teriparatide to manage primary osteoporosis [10]. The gene discussed is ESR1; the disease is osteoporosis.